Kynurenine and uric acid levels in chronic myeloid leukemia patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kynurenine and uric acid levels in chronic myeloid leukemia patients
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 3, Pages e992646
Publisher
Informa UK Limited
Online
2015-03-25
DOI
10.4161/2162402x.2014.992646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
- (2014) Ji-Young Choe et al. BMC CANCER
- Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)
- (2013) Anita C.A. Dankers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Expression of Indoleamine 2,3-Dioxygenase and Correlation With Pathological Malignancy in Gliomas
- (2013) Kentaro Mitsuka et al. NEUROSURGERY
- Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
- (2012) Vesa Lindström et al. Clinical Lymphoma Myeloma & Leukemia
- Indoleamine 2,3-dioxygenase, Tregs and Cancer
- (2012) D. H. Munn CURRENT MEDICINAL CHEMISTRY
- Comments on therapeutic cancer vaccines
- (2012) Vladimír Vonka Immunotherapy
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
- (2012) Giuseppina Bonanno et al. Journal of Translational Medicine
- Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
- (2012) Shamaila Munir et al. PLoS One
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma
- (2012) Jin Ye et al. VIRCHOWS ARCHIV
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms
- (2011) Lucile Capuron et al. BIOLOGICAL PSYCHIATRY
- Spontaneous Cytotoxic T-Cell Reactivity against Indoleamine 2,3-Dioxygenase-2
- (2011) R. B. Sorensen et al. CANCER RESEARCH
- IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway
- (2011) Hyunkeun Song et al. IMMUNOLOGY LETTERS
- Hyperuricemia in Pediatric Malignancies Before Treatment
- (2011) Ayako Nagai et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Vascular Endothelial Expression of Indoleamine 2,3-Dioxygenase 1 Forms a Positive Gradient towards the Feto-Maternal Interface
- (2011) Astrid Blaschitz et al. PLoS One
- Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC
- (2011) Lenka Krcmova et al. TALANTA
- Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
- (2010) R. B. Sorensen et al. BLOOD
- Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
- (2010) Zuzana Humlová et al. Clinical & Developmental Immunology
- Immunotherapy of chronic myeloid leukemia: present state and future prospects
- (2010) Vladimír Vonka Immunotherapy
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
- (2010) J. D. Mezrich et al. JOURNAL OF IMMUNOLOGY
- Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase
- (2010) Luciana Capece et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
- (2009) Hiroshi Urakawa et al. CLINICAL & EXPERIMENTAL METASTASIS
- IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes
- (2009) F. Fallarino et al. JOURNAL OF IMMUNOLOGY
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
- (2009) Agnieszka K. Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
- (2009) Yuzo Suzuki et al. LUNG CANCER
- High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
- (2008) Chantal Feder-Mengus et al. EUROPEAN JOURNAL OF CANCER
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started